Seres Therapeutics to Join Cantor 2024 Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 13, 2024 – Seres Therapeutics (Nasdaq: MCRB), a prominent company in the field of live biotherapeutics, has announced its participation in the upcoming Cantor Global Healthcare Conference. Representing the company, Eric Shaff, President and Chief Executive Officer, will deliver a presentation scheduled for September 18, 2024, at 3:05 p.m. ET. A video webcast of this presentation will be accessible in the “Events and Presentations” section under the “Investors and News” tab on Seres' website. The replay of the webcast will be available approximately one hour after the live event and will remain archived for 21 days.

About Seres Therapeutics

Seres Therapeutics, Inc. (Nasdaq: MCRB) is a commercial-stage biotechnology company at the forefront of developing live biotherapeutics aimed at improving health outcomes for patients in vulnerable medical conditions. The company achieved a significant milestone with the development and FDA approval of VOWST™, the first orally administered microbiome therapeutic. This breakthrough treatment is a testament to Seres’ commitment to pioneering innovative therapies.

Seres Therapeutics is also making strides with SER-155, a biotherapeutic designed to prevent infections stemming from the gastrointestinal tract, strengthen epithelial barrier integrity, and promote immune tolerance to decrease the occurrence of graft-versus-host disease. This development is particularly critical for transplant patients and those undergoing intensive treatments.

The company's ongoing research and development efforts extend to other live biotherapeutics targeted at patients with chronic liver disease, cancer neutropenia, and those who have undergone solid organ transplants. These initiatives highlight Seres Therapeutics' dedication to addressing the needs of medically vulnerable populations through cutting-edge biotherapeutic solutions.

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!